Meniere's Disease Clinical Research Study
If you suffer from Meniere's Disease, please consider this an invitation to join a clinical research study.
The main purpose of this Meniere's Disease research study is to evaluate the safety and effectiveness of OTO-104 in reducing the frequency of extreme vertigo (a feeling that your surroundings are moving when there is no actual movement), related to Meniere's Disease.
The U.S. Food and Drug Administration (FDA) has granted OTO-104 'Fast Track' designation. This is a process designed to facilitate the development and expedite the review of investigational drugs for serious conditions and for which no treatments currently exist.
Every study participant makes a difference
Each person with Meniere's who enrolls in this clinical research study moves us one step closer to the development of new future treatments. Clinical research is the key to finding new ways to prevent, diagnose, and treat Meniere's and other inner ear disorders. Without volunteers, clinical studies would not be possible. And without clinical studies, we would not be able to develop new future treatments that are safe and effective for people living with Meniere's.
If you or someone you know have been diagnosed with Meniere's Disease, please consider this as an invitation to participate in the clinical research study evaluation of an investigational medication called OTO-104, to see if it can help reduce the disabling attacks of dizziness/vertigo.
As a study participant, you would have access to study-related health care that may help you understand your disease, evaluate the safety and effectiveness of an investigational drug and additionally, the information gathered from the clinical study may help doctors improve treatment options in the future.
For more information or to see if you are potentially a candidate for this study, please call our Seal Beach office at (562)270-HEAR.